Helus Pharma to Present Topline Results from Phase 3 APPROACH Study Evaluating HLP003 as Adjunctive Treatment in Major Depressive Disorder on November 16, 2026
Company to host webcast at 8:00 a.m. EDT on Monday, November 16, 2026 Company to host webcast at 8:00 a.m. EDT on Monday, November 16, 2026